Table 2.

Disease activity before and after HCQ shortage

	Before shortage	After shortage	Paired t test	P value
CDAI in RA patients	11.47 ± 5.62	12.51 ± 5.97	1.86	0.063
SELENA in SLE patients	4.86 ± 3.78	5.88 ± 4.11	1.86	0.064

CDAI clinical disease activity index, RA rheumatoid arthritis, SELENA safety of estrogens in systemic lupus erythematosus national assessment, SLE systemic lupus erythematosus

*Significant P value if p < 0.05